Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Clinical trial NCT00422591 · COMPLETED
Trial details
- NCT number
- NCT00422591
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2017-01-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.